Gastrointestinal Cancer News

A review of established associations between cancer waiting times and treatment outcomes has identified discrepancies in the measurement and reporting of lag times between diagnosis and treatment.

Prenatal exposure in the 1960s and ’70s to dicyclomine, a component of the anti-nausea drug Bendectin, increased the risk for colorectal cancer in adult offspring, according to data reported in JNCI Cancer Spectrum.

The addition of zolbetuximab to capecitabine and oxaliplatin significantly extended PFS and OS for patients with claudin-18.2-positive/HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction cancer.

Machine learning algorithms can help predict positive resection margin and lymph node metastases among patients with pancreatic ductal adenocarcinoma, according to study results.

A colorectal cancer screening program in Denmark that used fecal immunochemical testing detected more cases among adults with diabetes and more cases at stage I of the disease than among those without diabetes, according to data published in Diabetic Medicine.

The concept of cancer vaccination has generated excitement in the scientific community for decades.

Major discrimination events appeared associated with increased frailty among Black survivors of various cancer types, according to study results published in Cancer.

Survival for patients with metastatic colorectal cancer has improved steadily since 2012, according to retrospective study results.

Edith P. Mitchell, MD, MACP, FCCP, FRCP (London), has been named enterprise vice president for cancer disparities at Jefferson Health’s Sidney Kimmel Cancer Center.

Colorectal cancer screenings more than doubled for adults aged 45 to 49 years after the U.S. Preventive Services Task Force lowered the recommended age to start screening, a study by Epic Research found.